Background: Metabolism of human chorionic gonadotropin (hCG) in the serum and kidney yields the terminal urinary product hCG ␤-core fragment (hCG␤cf), comprising two disulfide-linked peptides (␤6-␤40 and ␤55-␤92) of which one (␤6-␤40) retains truncated Nlinked sugars. Hyperglycosylated hCG␤cf may indicate choriocarcinoma or Down syndrome, but the glycosylation profile of hCG␤cf has not been thoroughly evaluated. Methods: hCG␤cf, purified from pregnancy urine, was reduced by "on-target" dithiothreitol (DTT) reduction and analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (
The heterodimeric placental hormone human chorionic gonadotropin (hCG) 3 is a widely studied member of the glycoprotein hormone family that includes luteinizing hormone, thyroid-stimulating hormone, and follicle-stimulating hormone. Each consists of a common ␣ subunit and a unique ␤ subunit that confers specific hormonal activity. hCG sustains early pregnancy by binding luteinizing hormone receptors at the corpus luteum surface and stimulating progesterone secretion until the placenta is able to carry out this function itself. In addition to being universally used as an early marker of pregnancy, hCG is monitored in sports drug testing (1 ) . The hCG ␤-subunit (hCG␤) is also a marker of various epithelial and gestational trophoblast carcinomas (2, 3 ) , where it may exert independent stimulatory activity (4, 5 ) . The precise structure of hCG has been well characterized by HPLC-mass spectrometry (6, 7 ) and by crystallographic analysis (8, 9 ) . Peptide mass mapping by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), using trypsin for digestion, has also been found to be a suitable technique for the identification of hCG and its subunits (10, 11 ) .
hCG, in common with other glycoprotein hormones, is characterized by sugar moieties on both subunits that determine receptor affinity and metabolic clearance. The currently accepted structural model of the N-linked carbohydrates found on hCG␤ is of a complex biantennary moiety terminating in sialic acid based on a trimannosyl core (12 ) . Despite the model, wide carbohydrate heterogeneity has been found. Mono-, bi-, and triantennary N-linked sugars occur in hCG␤ in both normal and abnormal pregnancies as well as in choriocarcinomas (12) (13) (14) (15) (16) (17) . An increase in the triantennary form seems to be a feature indicative of an abnormal state and may be of diagnostic value. In normal pregnancies, Elliott et al. (14 ) found that the biantennary form accounted for 76.5% of the N-linked oligosaccharide content of urinary hCG␤, that 21.6% was triantennary, and that the remainder was monoantennary (Fig. 1) . In gestational choriocarcinoma, by contrast, the triantennary content accounted for up to 63.6% of the total. A similar increase in hCG hyperglycosylation has been detected in Down syndrome by Cole et al. (18 ) . Indeed, an ELISA for hyperglycosylated hCG has been developed based on a monoclonal antibody raised to the hyperglycosylated variant (19, 20 ) . Prenatal diagnostic testing of maternal urine based on this ELISA is claimed to detect up to 97% of Down syndrome cases with a 5% false-positive rate when modeled with values of other markers (21 ) .
Similarly, carbohydrate heterogeneity remains in the terminal urinary degradation product of the ␤-subunit, the hCG ␤-core fragment (hCG␤cf). This core fragment has a primary structure of 73 amino acids, consisting of two polypeptides: ␤6-␤40 and ␤55-␤92, joined by four cystine residues (Fig. 2) . Only the ␤6-␤40 chain is glycosylated, retaining the two complex N-glycans linked to asparagine residues 13 and 30. However, as a consequence of metabolism, these branched chain carbohydrates are truncated. Various studies of the carbohydrate structure of hCG␤cf using a combination of immunoaffinity, gel-filtration, and ion-exchange chromatography, glycosidase digestion, hydrazinolysis, and periodate oxidation have been reported (22) (23) (24) (25) (26) . A population of shortened mono-and biantennary carbohydrate cores has been suggested, which may or may not be fucosylated (22 ) . There is disagreement over whether these moieties possess sialic acid or galactose residues, although there is some evidence that they do extend beyond the trimannosyl cores (24 ) . In an attempt to help resolve this disagreement, we investigated the structural variation in these oligosaccharide moieties, using an alternative approach that incorporates analysis by MALDI-TOF MS.
MALDI-TOF MS is a powerful tool for determining the mass of macromolecules, as first reported by Karas and Hillenkamp (27 ) , yielding signals that correspond mainly to singly charged molecular ions. Chemical or enzymatic cleavage of posttranslationally modified proteins, followed by MALDI-TOF MS analysis, has been used for the purpose of structural characterization. Exoglycosidase digestion with MALDI-TOF MS analysis has been used to elucidate carbohydrate sequences and composition of glycoproteins (28 ) . Nonetheless, at first glance, this approach appears to be overcomplicated for investigating the glycoforms of hCG␤cf, particularly because the branch chain sequence is unlikely to be affected by metabolism of the ␤-subunit, albeit that the chain is truncated. Indeed, exoglycosidase digestion could confound interpretation of results because absolute specificity for one substrate is rare and this may possibly lead to the presence of artifacts. However, direct analysis of hCG␤cf by low-resolution MALDI-TOF MS is not sufficiently discriminating to identify individual glycoforms because of the lack of resolution between them. A simple but potentially useful approach could be to reduce the disulfide bonds, e.g., with DTT, to yield the two separate polypeptide chains before analysis. Separation of the ␤55-␤92 chain, which is of no diagnostic value, from the ␤6-␤40 chain is advantageous because the overall masses of the glycoproteins being analyzed are reduced, which is conducive to discriminating between them. The mass of each glycosylation variant on the ␤6-␤40 chain can then be determined by calculating the difference in mass between each peak observed to the mass of its corresponding primary amino acid sequence, i.e., nonglycosylated ␤6-␤40. The presence of residual triantennary sugars on hCG␤cf has not been as well determined as for free hCG␤ but should be characterized to determine any diagnostic potential. In this study, we used MALDI-TOF MS, for the first time, to directly observe and determine the number of glycoforms in a purified sample of pooled pregnancy hCG␤cf.
Materials and Methods materials
The hCG␤cf used in this study was isolated from crude urinary hCG (Sigma) and characterized previously (29 ) . DTT, for the reduction of disulfide bonds, and NH 4 HCO 3 Fig. 1 . Structures of the asialo asparagine-linked oligosaccharides of the hCG␤ subunit from normal pregnancy, hydatidiform mole, choriocarcinoma (I, III, and IV, respectively), and gestational diabetes (II).
Adapted from Elliott et al. (14 ) .
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were obtained from Sigma-Aldrich. The MALDI-TOF MS matrix 3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid; SA) was also purchased from Sigma-Aldrich and used without further purification. Acetonitrile and trifluoroacetic acid (TFA) were of analytical grade and obtained from Merck.
maldi-tof ms
To acquire spectra of the nonreduced molecule, we ap- A pulsed nitrogen laser ( max ϭ 337 nm) was used to desorb ions from the samples, which were detected by a microchannel plate detector at a sampling rate of 500 MHz. Spectra were generated by summing 30 -40 laser shots. Data were acquired from both instruments operating in the positive linear mode.
treatment of results
Initially, the peak relating to the nonglycosylated hCG␤cf peptide (␤55-␤92) was internally calibrated to the average molecular mass of its given primary sequence, [MϩH] To determine the inferred mass values of the hCG␤cf carbohydrate moieties, we subtracted the average molecular mass ([MϩH] ϩ 3752.4) of the primary sequence of the glycosylated hCG␤cf polypeptide (␤6-␤40) from the mass ([MϩH] ϩ ) values of the acquired peaks ( Table 1 ). The carbohydrate content of these peaks was then deduced by the sequential subtraction of the masses of the sugar residues present in hCG ␤-subunit carbohydrates (Table  2) . Carbohydrate structures (Table 3) could then be predicted from the deduced monosaccharide content, taking into account the very small difference between the calculated and the observed masses (Յ0.15%). Different combinations of carbohydrate structures are shown where the mass of a peak indicated several monosaccharides from which several permutations could be construed. Although this study did not yield any conformational information, the anomeric glycosidic linkages within the carbohydrate structures in Table 3 have been described previously (14 ) and were used in our analysis.
Results
SA was selected as the MALDI-TOF MS matrix of choice for this investigation because other standard matrices used in protein analysis, ␣-cyano-4-hydoxycinnamic acid and sDHB [a 9:1 (by weight) mixture of 2,5-dihydroxybenzoic acid and 5-methoxysalicylic acid], did not yield intense spectra for hCG␤cf (data not shown). A typical spectrum of hCG␤cf obtained by MALDI-TOF MS using SA is shown in Fig. 3 . The spectrum is characterized by a broad triple peak at m/z 8700 -11300 with discernible peaks at m/z 9110, 9930, and 10770. After reduction with DTT (Fig. 4) , the triple peak disappeared and was replaced by a set of resolved peaks between m/z 4156 and 6354. The initial peak (Fig. 4) , at m/z 4164.2, was presumed to arise from the nonglycosylated hCG␤cf peptide chain (␤55-␤92) because the m/z value is within the 0.5% error allowed for the linear mode of the MALDI instrument. To obtain corrected values for the remaining peaks, this peak was internally calibrated to the average molecular mass of the given primary sequence, [MϩH] ϩ 4156.8 (calculated using the Protein Abacus computer software). Despite the fact that hCG␤cf asparagine-linked carbohydrate moieties were not observed directly, the low percentage errors between the observed and the expected mass values of the peaks acquired show that it is likely that real glycoforms were detected (Table 1) .
Carbohydrate moieties, shown in Table 3 , were determined as described above. Peak 1 (m/z 4630.2) arises from a polypeptide possessing a single truncated and fucosylated monoantennary oligosaccharide (Man 2 GlcNAc 2 Fuc) with a predicted mass of 876.8, whereas the polypeptide giving rise to peak 2 (m/z 4819.6) has two shortened fucosylated monoantennary sugars (ManGlcNAc 2 Fuc and GlcNAc 2 Fuc) with a predicted mass of 1064.0. Peaks 6 (m/z 5677.9) and 7 (m/z 5821.1) apparently arise from hCG␤cf glycoforms containing two N-linked trimannosyl core carbohydrates (Man 3 GlcNAc 2 ). In peak 6, a single trimannosyl core possesses fucose (with a predicted mass of 1931.8), whereas both are fucosylated in peak 7 (with a predicted mass of 2077.9). The combination of monosaccharide residues (with a predicted mass of 2420.3) that make up the glycoform observed at peak 8 (m/z 6179.0) can be configured to produce an identical pair of sugar structures that are shortened versions (GlcNAc 2 Man 2 GlcNAc 2 ) of carbohydrate structures II or IV found by Elliott et al. (14 ) . The number of monosaccharide residues calculated for the polypeptides giving mass spectral peaks 3-5 and peak 9 precludes the determination of a single pair of glycoforms, and for these alternative structures have been suggested. The predicted mass of 1242.2 for the carbohydrate moiety of the glycoform at peak 3 (m/z 5000.8) indicates either a single fucosylated trimannosyl core attached to a monoantennary N-acetylglucosamine (Man 3 GlcNAc 3 Fuc) or a trimannosyl core (Man 3 GlcNAc 2 ) at one glycosylation site and a single GlcNAc at the other, one of which is fucosylated. Peak 4 (m/z 5358.2) indicates a glycoform with a predicted carbohydrate mass of 1607.5, which can translate to two shortened core sugars (Man 2 GlcNAc 2 ) differing by a fucose residue. An alternative combination includes a trimannosyl core and a shortened core (ManGlcNAc 2 ), one of which is fucosylated. Similarly, the predicted carbohydrate mass (1769.6) for the glycoform seen at peak 5 (m/z 5517.6) indicates a monosaccharide content from which may be constructed a trimannosyl core (Man 3 GlcNAc 2 ) and a truncated core oligosaccharide (Man 2 GlcNAc 2 ), one of which is connected to a fucose residue. Finally, two extended trimannosyl cores (Man 3 GlcNAc 4 ) can be inferred from a predicted carbohydrate mass of 2598.4 of the glycopeptide at peak 9 (m/z 6353.8). Structures construed from this mass may be pairs or a combination of truncated oligosaccharides II, III, or IV in Fig. 1 . There is an additional peak in the mass spectra of DTT-reduced hCG␤cf between peaks 3 and 4 that we assume to be an additional glycoform but for which the data analysis software was unable to acquire a value.
Discussion
Direct carbohydrate analyses of hCG␤cf in previous studies have generally suggested that the metabolite retains shortened hCG␤ asparagine-linked oligosaccharides that b Difference between the calculated mass of the expected total carbohydrate and the inferred mass after subtraction of the mass of the primary sequence from the peak mass. c Where the total area under peaks 1-9 in Fig. 2 equals 100% . have been trimmed back to their trimannosyl cores and smaller sugars (22) (23) (24) (25) (26) . In addition, de Medeiros et al. (24 ) found that 22-44% of hCG␤cf molecules were not bound by the lectin concanavalin A, and of those 88% were completely deprived of any carbohydrate content. After DTT reduction, our MALDI-TOF MS data indicated the presence of only one nonglycosylated peptide at m/z 4156.8 within the dipeptide molecule. If the usually glycosylated peptide (␤6-␤40) had been completely lacking in carbohydrate, then a peak at m/z 3752.4 should have been apparent in the mass spectrum of reduced hCG␤cf. This peak was not observed at all in any of the spectra Fig. 3 . MALDI-TOF mass spectrum of purified hCG␤cf in SA matrix generated by summation of the signals from 40 laser shots and calibrated externally using horse heart cytochrome C (M r 12 360.1). Fig. 4 . MALDI-TOF mass spectrum of hCG␤cf after "on-target" DTT reduction and using SA matrix.
The spectrum was generated by summation of the signals from 30 laser shots and calibrated internally using fragment mass [MϩH] ϩ 4156.8. Peaks 1-9 are described in the text.
acquired from reduced hCG␤cf. Additionally, our MALDI analysis of hCG␤cf confirms the lack of sialic acid as expected but also the lack of any galactose in this preparation.
The galactose content of hCG␤cf has been reported differently. Direct carbohydrate analyses after acid hydrolysis (24 ) or conversion of sugars to glycamines (23 ) has detected small amounts of galactose. Conversely, indirect analysis has found hCG␤cf N-linked sugars lacking in the monosaccharide (22, 25 ) . The observation that hCG␤cf is not bound by galactose-specific Ricinus communis agglutinin-agarose affinity matrix (23, 25 ) has been attributed to the inability of the matrix to bind one galactose residue per N-linked sugar, whereas contaminating glycoprotein is thought to account for hCG␤cf galactose detected directly (22 ) . This direct MALDI-TOF MS analysis indicated that no galactose was present in the N-linked sugars of the sample we investigated. It is uncertain where the degradation of hCG carbohydrates occurs. In their study of hCG␤ separated from intact urinary hCG, Liu and Bowers (7 ) detected a range of both sialated and asialo mono-, bi-, and triantennary N-linked oligosaccharides. It would therefore seem likely that the majority of sialic acid and galactose residues are lost as hCG is processed to hCG␤cf after renal reabsorption. Whether or not this is the case, our results indicate that hCG␤cf possesses neither sialic acid nor galactose residues. In fact, the glycoforms that appear to be present in hCG␤cf range from a single GlcNAc residue to more complex structures extending beyond the trimannosyl core. The largest carbohydrate structures inferred by our results, peaks 8 and 9 in Fig. 4 , may arise from degraded forms of the sugars II and IV in Fig. 1 , determined by Elliott et al. (14 ) in hCG␤.
Absolute quantification of the relative amounts of each N-linked carbohydrate moiety was not possible using this method. Semiquantification of relative amounts of glycoform pairs was possible by determining the areas under the peaks of the reduced peptides. Unfortunately, many peaks could have arisen from multiple combinations of sugars. However, the monosaccharides determined from peak 8 (see Table 3 ) give rise to a combination of only two carbohydrates moieties that may arise from shortened triantennary oligosaccharides. This peak comprised 15.6% of the carbohydrate content of this sample, which is in agreement with the triantennary content of normal pregnancy hCG ␤-subunits as determined by Elliott et al. (14 ) . Because the crude preparation from which this hCG␤cf was prepared may have contained urinary hCG␤ from not necessarily normal pregnancies, it is impossible to say whether the larger sugar moieties we observed originated from either the triantennary carbohydrate (IV in Fig. 1 ) seen in normal or aberrant pregnancies or the biantennary sugar (II in Fig. 1 ) observed almost exclusively in gestational diabetes (14 ) .
In conclusion, the percentage abundance of other glycoforms detected by MALDI-TOF MS indicates that it is likely that the microheterogeneity of the hCG␤ N-linked carbohydrates found by Elliott et al. (14 ) is conserved in hCG ␤-core fragments from all normal and aberrant pregnancies. Although not precisely defining hCG␤cf glycosylation, the MALDI-TOF mass spectrum of DTTreduced hCG␤cf produces what appears to be a distinctive "fingerprint". For example, peaks of higher mass attributable to the increased triantennary sugar content of hCG␤cf would be expected to increase in area in the spectra of hCG ␤-core fragments from individuals with abnormal or Down syndrome pregnancies and choriocarcinoma. Until now, definitive testing for hyperglycosylation in hCG in patient urine has required multiple precipitation and chromatographic steps (31 ) followed by thiol reduction, glycan release, and HPLC (14 ) . This is an approach that may be considered too time-consuming for routine clinical biochemistry. Although an extract of hCG␤cf was analyzed in our current investigation, MALDI-TOF MS analysis of unextracted urine samples from pregnant women shows a broad peak corresponding to protonated hCG␤cf, indicating that its concentration in pregnancy urine is sufficiently high for detection purposes. Further study will help to elucidate whether the reductive technique described here can be applied to pregnancy or choriocarcinoma urine, possibly after desalting and concentration by centrifugal ultrafiltration (10 ) . The potential clinical utility for distinguishing between normal pregnancy and Down syndrome pregnancy by this approach needs to be demonstrated and is currently under investigation.
